Opdivo

Opdivo

Basic Prescribing Info
Contents
Nivolumab
MIMS Class
Targeted Cancer Therapy / Cancer Immunotherapy
ATC Classification
L01FF01 - nivolumab ; Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in